Literature DB >> 16748468

A note on the disturbance of the haemoglobin metabolism of the rat by sulphanilamide.

J W Legge1.   

Abstract

Entities:  

Keywords:  HEMOGLOBIN AND HEMOGLOBIN COMPOUNDS; SULFONAMIDES/effects

Mesh：

Substances：

Year:  1949        PMID： 16748468      PMCID： PMC1274815          DOI： 10.1042/bj0440105

Source DB:  PubMed          Journal:  Biochem J        ISSN： 0264-6021            Impact factor:   3.857


× No keyword cloud information.
  6 in total

1.  The role of the aromatic amino group in deranged pigment metabolism.

Authors:  G Brownlee
Journal:  Biochem J       Date:  1939-05       Impact factor: 3.857

2.  Coupled oxidation of ascorbic acid and haemoglobin: Studies on the formation of bile pigments from choleglobin and verdohaemochromogen and on their isolation from erythrocytes.

Authors:  R Lemberg; W H Lockwood; J W Legge
Journal:  Biochem J       Date:  1941-03       Impact factor: 3.857

3.  Porphyrinuric action of 2-(p-aminobenzenesulphonamido)pyridine (M and B 693). Comparison with sulphanilamide.

Authors:  C Rimington
Journal:  Biochem J       Date:  1940-01       Impact factor: 3.857

4.  Coupled oxidation of ascorbic acid and haemoglobin: Quantitative studies on choleglobin formation. Estimation of haemoglobin and ascorbic acid oxidations.

Authors:  R Lemberg; J W Legge; W H Lockwood
Journal:  Biochem J       Date:  1941-03       Impact factor: 3.857

5.  Reduction of biliverdin to bilirubin in tissues.

Authors:  R Lemberg; R A Wyndham
Journal:  Biochem J       Date:  1936-07       Impact factor: 3.857

6.  Porphyrins and Their Relation to the Metabolism of Blood Pigments: (Section of Therapeutics and Pharmacology).

Authors:  C Rimington
Journal:  Proc R Soc Med       Date:  1939-08
  6 in total
  2 in total

1.  Recent studies of the urobilin problem.

Authors:  C J WATSON
Journal:  J Clin Pathol       Date:  1963-01       Impact factor: 3.411

2.  Bilirubin and urobilins in germfree, ex-germfree, and conventional rats.

Authors:  B E GUSTAFSSON; L S LANKE
Journal:  J Exp Med       Date:  1960-12-01       Impact factor: 14.307
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.